BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 19064572)

  • 1. Polymorphism in the IL18 gene and epithelial ovarian cancer in non-Hispanic white women.
    Palmieri RT; Wilson MA; Iversen ES; Clyde MA; Calingaert B; Moorman PG; Poole C; Anderson AR; Anderson S; Anton-Culver H; Beesley J; Hogdall E; Brewster W; Carney ME; Chen X; Chenevix-Trench G; Chang-Claude J; Cunningham JM; Dicioccio RA; Doherty JA; Easton DF; Edlund CK; Gayther SA; Gentry-Maharaj A; Goode EL; Goodman MT; Kjaer SK; Hogdall CK; Hopkins MP; Jenison EL; Blaakaer J; Lurie G; McGuire V; Menon U; Moysich KB; Ness RB; Pearce CL; Pharoah PD; Pike MC; Ramus SJ; Rossing MA; Song H; Terada KY; Vandenberg D; Vierkant RA; Wang-Gohrke S; Webb PM; Whittemore AS; Wu AH; Ziogas A; Berchuck A; Schildkraut JM; ; ;
    Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3567-72. PubMed ID: 19064572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphism in the GALNT1 gene and epithelial ovarian cancer in non-Hispanic white women: the Ovarian Cancer Association Consortium.
    Phelan CM; Tsai YY; Goode EL; Vierkant RA; Fridley BL; Beesley J; Chen XQ; Webb PM; Chanock S; Cramer DW; Moysich K; Edwards RP; Chang-Claude J; Garcia-Closas M; Yang H; Wang-Gohrke S; Hein R; Green AC; Lissowska J; Carney ME; Lurie G; Wilkens LR; Ness RB; Pearce CL; Wu AH; Van Den Berg DJ; Stram DO; Terry KL; Whiteman DC; Whittemore AS; DiCioccio RA; McGuire V; Doherty JA; Rossing MA; Anton-Culver H; Ziogas A; Hogdall C; Hogdall E; Krüger Kjaer S; Blaakaer J; Quaye L; Ramus SJ; Jacobs I; Song H; Pharoah PD; Iversen ES; Marks JR; Pike MC; Gayther SA; Cunningham JM; Goodman MT; Schildkraut JM; Chenevix-Trench G; Berchuck A; Sellers TA; ;
    Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):600-4. PubMed ID: 20142253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot".
    Johnatty SE; Beesley J; Chen X; Macgregor S; Duffy DL; Spurdle AB; deFazio A; Gava N; Webb PM; Rossing MA; Doherty JA; Goodman MT; Lurie G; Thompson PJ; Wilkens LR; Ness RB; Moysich KB; Chang-Claude J; Wang-Gohrke S; Cramer DW; Terry KL; Hankinson SE; Tworoger SS; Garcia-Closas M; Yang H; Lissowska J; Chanock SJ; Pharoah PD; Song H; Whitemore AS; Pearce CL; Stram DO; Wu AH; Pike MC; Gayther SA; Ramus SJ; Menon U; Gentry-Maharaj A; Anton-Culver H; Ziogas A; Hogdall E; Kjaer SK; Hogdall C; Berchuck A; Schildkraut JM; Iversen ES; Moorman PG; Phelan CM; Sellers TA; Cunningham JM; Vierkant RA; Rider DN; Goode EL; Haviv I; Chenevix-Trench G; ; ;
    PLoS Genet; 2010 Jul; 6(7):e1001016. PubMed ID: 20628624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk.
    Chornokur G; Lin HY; Tyrer JP; Lawrenson K; Dennis J; Amankwah EK; Qu X; Tsai YY; Jim HS; Chen Z; Chen AY; Permuth-Wey J; Aben KK; Anton-Culver H; Antonenkova N; Bruinsma F; Bandera EV; Bean YT; Beckmann MW; Bisogna M; Bjorge L; Bogdanova N; Brinton LA; Brooks-Wilson A; Bunker CH; Butzow R; Campbell IG; Carty K; Chang-Claude J; Cook LS; Cramer DW; Cunningham JM; Cybulski C; Dansonka-Mieszkowska A; du Bois A; Despierre E; Dicks E; Doherty JA; Dörk T; Dürst M; Easton DF; Eccles DM; Edwards RP; Ekici AB; Fasching PA; Fridley BL; Gao YT; Gentry-Maharaj A; Giles GG; Glasspool R; Goodman MT; Gronwald J; Harrington P; Harter P; Hein A; Heitz F; Hildebrandt MA; Hillemanns P; Hogdall CK; Hogdall E; Hosono S; Jakubowska A; Jensen A; Ji BT; Karlan BY; Kelemen LE; Kellar M; Kiemeney LA; Krakstad C; Kjaer SK; Kupryjanczyk J; Lambrechts D; Lambrechts S; Le ND; Lee AW; Lele S; Leminen A; Lester J; Levine DA; Liang D; Lim BK; Lissowska J; Lu K; Lubinski J; Lundvall L; Massuger LF; Matsuo K; McGuire V; McLaughlin JR; McNeish I; Menon U; Milne RL; Modugno F; Moysich KB; Ness RB; Nevanlinna H; Eilber U; Odunsi K; Olson SH; Orlow I; Orsulic S; Weber RP; Paul J; Pearce CL; Pejovic T; Pelttari LM; Pike MC; Poole EM; Risch HA; Rosen B; Rossing MA; Rothstein JH; Rudolph A; Runnebaum IB; Rzepecka IK; Salvesen HB; Schernhammer E; Schwaab I; Shu XO; Shvetsov YB; Siddiqui N; Sieh W; Song H; Southey MC; Spiewankiewicz B; Sucheston L; Teo SH; Terry KL; Thompson PJ; Thomsen L; Tangen IL; Tworoger SS; van Altena AM; Vierkant RA; Vergote I; Walsh CS; Wang-Gohrke S; Wentzensen N; Whittemore AS; Wicklund KG; Wilkens LR; Wu AH; Wu X; Woo YL; Yang H; Zheng W; Ziogas A; Hasmad HN; Berchuck A; ; ; Iversen ES; Schildkraut JM; Ramus SJ; Goode EL; Monteiro AN; Gayther SA; Narod SA; Pharoah PD; Sellers TA; Phelan CM
    PLoS One; 2015; 10(6):e0128106. PubMed ID: 26091520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms in BRCA1 and BRCA2 and risk of epithelial ovarian cancer.
    Wenham RM; Schildkraut JM; McLean K; Calingaert B; Bentley RC; Marks J; Berchuck A
    Clin Cancer Res; 2003 Oct; 9(12):4396-403. PubMed ID: 14555511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variation in insulin-like growth factor 2 may play a role in ovarian cancer risk.
    Pearce CL; Doherty JA; Van Den Berg DJ; Moysich K; Hsu C; Cushing-Haugen KL; Conti DV; Ramus SJ; Gentry-Maharaj A; Menon U; Gayther SA; Pharoah PD; Song H; Kjaer SK; Hogdall E; Hogdall C; Whittemore AS; McGuire V; Sieh W; Gronwald J; Medrek K; Jakubowska A; Lubinski J; Chenevix-Trench G; ; Beesley J; Webb PM; Berchuck A; Schildkraut JM; Iversen ES; Moorman PG; Edlund CK; Stram DO; Pike MC; Ness RB; Rossing MA; Wu AH
    Hum Mol Genet; 2011 Jun; 20(11):2263-72. PubMed ID: 21422097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D receptor (VDR) polymorphisms and risk of ovarian cancer in Caucasian and African American women.
    Grant DJ; Hoyo C; Akushevich L; Iversen ES; Whitaker R; Marks J; Berchuck A; Schildkraut JM
    Gynecol Oncol; 2013 Apr; 129(1):173-8. PubMed ID: 23262379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk.
    Amankwah EK; Lin HY; Tyrer JP; Lawrenson K; Dennis J; Chornokur G; Aben KK; Anton-Culver H; Antonenkova N; Bruinsma F; Bandera EV; Bean YT; Beckmann MW; Bisogna M; Bjorge L; Bogdanova N; Brinton LA; Brooks-Wilson A; Bunker CH; Butzow R; Campbell IG; Carty K; Chen Z; Chen YA; Chang-Claude J; Cook LS; Cramer DW; Cunningham JM; Cybulski C; Dansonka-Mieszkowska A; du Bois A; Despierre E; Dicks E; Doherty JA; Dörk T; Dürst M; Easton DF; Eccles DM; Edwards RP; Ekici AB; Fasching PA; Fridley BL; Gao YT; Gentry-Maharaj A; Giles GG; Glasspool R; Goodman MT; Gronwald J; Harrington P; Harter P; Hasmad HN; Hein A; Heitz F; Hildebrandt MA; Hillemanns P; Hogdall CK; Hogdall E; Hosono S; Iversen ES; Jakubowska A; Jensen A; Ji BT; Karlan BY; Jim H; Kellar M; Kiemeney LA; Krakstad C; Kjaer SK; Kupryjanczyk J; Lambrechts D; Lambrechts S; Le ND; Lee AW; Lele S; Leminen A; Lester J; Levine DA; Liang D; Lim BK; Lissowska J; Lu K; Lubinski J; Lundvall L; Massuger LF; Matsuo K; McGuire V; McLaughlin JR; McNeish I; Menon U; Milne RL; Modugno F; Moysich KB; Ness RB; Nevanlinna H; Eilber U; Odunsi K; Olson SH; Orlow I; Orsulic S; Weber RP; Paul J; Pearce CL; Pejovic T; Pelttari LM; Permuth-Wey J; Pike MC; Poole EM; Risch HA; Rosen B; Rossing MA; Rothstein JH; Rudolph A; Runnebaum IB; Rzepecka IK; Salvesen HB; Schernhammer E; Schwaab I; Shu XO; Shvetsov YB; Siddiqui N; Sieh W; Song H; Southey MC; Spiewankiewicz B; Sucheston-Campbell L; Teo SH; Terry KL; Thompson PJ; Thomsen L; Tangen IL; Tworoger SS; van Altena AM; Vierkant RA; Vergote I; Walsh CS; Wang-Gohrke S; Wentzensen N; Whittemore AS; Wicklund KG; Wilkens LR; Wu AH; Wu X; Woo YL; Yang H; Zheng W; Ziogas A; Kelemen LE; Berchuck A; ; Schildkraut JM; Ramus SJ; Goode EL; Monteiro AN; Gayther SA; Narod SA; Pharoah PD; Sellers TA; Phelan CM
    Genet Epidemiol; 2015 Dec; 39(8):689-97. PubMed ID: 26399219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of IL-27 polymorphisms and the susceptibility to epithelial ovarian cancer in a Chinese population.
    Zhang Z; Zhou B; Wu Y; Gao Q; Zhang K; Song Y; Zhang L; Xi M
    Immunogenetics; 2014 Feb; 66(2):85-92. PubMed ID: 24352695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between single-nucleotide polymorphisms in hormone metabolism and DNA repair genes and epithelial ovarian cancer: results from two Australian studies and an additional validation set.
    Beesley J; Jordan SJ; Spurdle AB; Song H; Ramus SJ; Kjaer SK; Hogdall E; DiCioccio RA; McGuire V; Whittemore AS; Gayther SA; Pharoah PD; Webb PM; Chenevix-Trench G; ; ;
    Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2557-65. PubMed ID: 18086758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of single nucleotide polymorphisms in glycosylation genes with risk of epithelial ovarian cancer.
    Sellers TA; Huang Y; Cunningham J; Goode EL; Sutphen R; Vierkant RA; Kelemen LE; Fredericksen ZS; Liebow M; Pankratz VS; Hartmann LC; Myer J; Iversen ES; Schildkraut JM; Phelan C
    Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):397-404. PubMed ID: 18268124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ESR1/SYNE1 polymorphism and invasive epithelial ovarian cancer risk: an Ovarian Cancer Association Consortium study.
    Doherty JA; Rossing MA; Cushing-Haugen KL; Chen C; Van Den Berg DJ; Wu AH; Pike MC; Ness RB; Moysich K; Chenevix-Trench G; Beesley J; Webb PM; Chang-Claude J; Wang-Gohrke S; Goodman MT; Lurie G; Thompson PJ; Carney ME; Hogdall E; Kjaer SK; Hogdall C; Goode EL; Cunningham JM; Fridley BL; Vierkant RA; Berchuck A; Moorman PG; Schildkraut JM; Palmieri RT; Cramer DW; Terry KL; Yang HP; Garcia-Closas M; Chanock S; Lissowska J; Song H; Pharoah PD; Shah M; Perkins B; McGuire V; Whittemore AS; Di Cioccio RA; Gentry-Maharaj A; Menon U; Gayther SA; Ramus SJ; Ziogas A; Brewster W; Anton-Culver H; ; ; Pearce CL;
    Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):245-50. PubMed ID: 20056644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a new putative functional IL18 gene variant through an association study in systemic lupus erythematosus.
    Sánchez E; Palomino-Morales RJ; Ortego-Centeno N; Jiménez-Alonso J; González-Gay MA; López-Nevot MA; Sánchez-Román J; de Ramón E; González-Escribano MF; Pons-Estel BA; D'Alfonso S; Sebastiani GD; ; Alarcón-Riquelme ME; Martín J
    Hum Mol Genet; 2009 Oct; 18(19):3739-48. PubMed ID: 19584085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inherited common variants in mitochondrial DNA and invasive serous epithelial ovarian cancer risk.
    Earp MA; Brooks-Wilson A; Cook L; Le N
    BMC Res Notes; 2013 Oct; 6():425. PubMed ID: 24148579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between Genetically Proxied Inhibition of HMG-CoA Reductase and Epithelial Ovarian Cancer.
    Yarmolinsky J; Bull CJ; Vincent EE; Robinson J; Walther A; Smith GD; Lewis SJ; Relton CL; Martin RM
    JAMA; 2020 Feb; 323(7):646-655. PubMed ID: 32068819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic polymorphisms in the Paraoxonase 1 gene and risk of ovarian epithelial carcinoma.
    Lurie G; Wilkens LR; Thompson PJ; McDuffie KE; Carney ME; Terada KY; Goodman MT
    Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):2070-7. PubMed ID: 18708400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of common genetic variants in ovarian cancer susceptibility and outcome: progress to date from the Ovarian Cancer Association Consortium (OCAC).
    Bolton KL; Ganda C; Berchuck A; Pharaoh PD; Gayther SA
    J Intern Med; 2012 Apr; 271(4):366-78. PubMed ID: 22443200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STAT3 polymorphisms may predict an unfavorable response to first-line platinum-based therapy for women with advanced serous epithelial ovarian cancer.
    Permuth-Wey J; Fulp WJ; Reid BM; Chen Z; Georgeades C; Cheng JQ; Magliocco A; Chen DT; Lancaster JM
    Int J Cancer; 2016 Feb; 138(3):612-9. PubMed ID: 26264211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of a common variant of SYNPO2 gene with increased risk of serous epithelial ovarian cancer.
    Ma L; Zhang W; Ding Z; Wu SG; Jin Y; Jiang N; Du H; Cai D; Miao L; Chen X
    Tumour Biol; 2017 Feb; 39(2):1010428317691185. PubMed ID: 28231729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphisms in the MUC16 gene: potential implication in epithelial ovarian cancer.
    Bouanene H; Hadj Kacem H; Ben Fatma L; Ben Limem H; Ben Ahmed S; Yakoub S; Miled A
    Pathol Oncol Res; 2011 Jun; 17(2):295-9. PubMed ID: 21046495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.